BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23335325)

  • 1. SOCS and diabetes--ups and downs of a turbulent relationship.
    Suchy D; Łabuzek K; Machnik G; Kozłowski M; Okopień B
    Cell Biochem Funct; 2013 Apr; 31(3):181-95. PubMed ID: 23335325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressors of cytokine signaling (SOCS) and type 2 diabetes.
    Feng X; Tang H; Leng J; Jiang Q
    Mol Biol Rep; 2014; 41(4):2265-74. PubMed ID: 24414000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS proteins causing trouble in insulin action.
    Lebrun P; Van Obberghen E
    Acta Physiol (Oxf); 2008 Jan; 192(1):29-36. PubMed ID: 18171427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity.
    Galic S; Sachithanandan N; Kay TW; Steinberg GR
    Biochem J; 2014 Jul; 461(2):177-88. PubMed ID: 24966052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study of polymorphisms in SOCS family genes with type 1 diabetes mellitus.
    Ni R; Ihara K; Miyako K; Takemoto M; Ishimura M; Kohno H; Matsuura N; Yoshimura A; Hara T
    Int J Immunogenet; 2006 Feb; 33(1):7-10. PubMed ID: 16426235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No non-redundant function of suppressor of cytokine signaling 2 in insulin producing β-cells.
    Puff R; Dames P; Weise M; Göke B; Parhofer K; Lechner A
    Islets; 2010; 2(4):252-7. PubMed ID: 21099320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: comparison between different genotypes and core protein sequence analysis.
    Pascarella S; Clément S; Guilloux K; Conzelmann S; Penin F; Negro F
    J Med Virol; 2011 Jun; 83(6):1005-15. PubMed ID: 21503913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes.
    Mokhtari D; Welsh N
    Clin Sci (Lond); 2009 Nov; 118(4):241-7. PubMed ID: 19886867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Macrophages: Versatile Gatekeepers During Pancreatic β-Cell Development, Injury, and Regeneration.
    Van Gassen N; Staels W; Van Overmeire E; De Groef S; Sojoodi M; Heremans Y; Leuckx G; Van de Casteele M; Van Ginderachter JA; Heimberg H; De Leu N
    Stem Cells Transl Med; 2015 Jun; 4(6):555-63. PubMed ID: 25848123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new pair of SOCS for diabetic nephropathy.
    Brosius FC; Banes-Berceli A
    J Am Soc Nephrol; 2010 May; 21(5):723-4. PubMed ID: 20413610
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of β-cell function: a translational journey from the bench to the bedside.
    Goldfine AB; Kulkarni RN
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():152-60. PubMed ID: 22928576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of diabetic maculopathy with diabetic nephropathy--a study.
    Biswas G; Dutta S; Mandal S; Biswas MC; Banerjee S; Saha SJ
    J Indian Med Assoc; 2002 Sep; 100(9):567-8. PubMed ID: 12455389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy.
    Gu T; Horová E; Möllsten A; Seman NA; Falhammar H; Prázný M; Brismar K; Gu HF
    J Diabetes Complications; 2012; 26(5):393-8. PubMed ID: 22770937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A community-based epidemiologic study of gender differences in the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type 2 diabetic patients in Kinmen, Taiwan.
    Liu JH; Tung TH; Tsai ST; Chou P; Chuang SY; Chen SJ; Lee FL; Shih HC; Li WL
    Ophthalmologica; 2006; 220(4):252-8. PubMed ID: 16785757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver.
    Baltayiannis G; Baltayiannis N; Tsianos EV
    J BUON; 2008; 13(2):263-5. PubMed ID: 18555475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins.
    Dalpke A; Heeg K; Bartz H; Baetz A
    Immunobiology; 2008; 213(3-4):225-35. PubMed ID: 18406369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
    Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
    Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.